Stocks gave up earlier gains Friday as the White House reaffirmed President Donald Trump’s plan to implement some of his long ...

ArcBest’s fourth-quarter results were ahead of analysts’ expectations but reflect a sluggish demand environment.

The Fed's preferred inflation gauge, the personal consumption and expenditures index, rose 0.3% from November and 2.6% on an ...

The Federal Reserve's favorite inflation gauge showed prices increased slightly in December 2024. Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial ...

The Federal Reserve's favorite inflation gauge showed prices increased slightly in December 2024. Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial ...

The Bitcoin monthly returns table for the past twelve years shows that BTC rallied 10 out of 12 times. In 2024, Bitcoin gained 43.55%, in 2023, during the bear market phase BTC price was nearly ...

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

Metsera, along with Maze Therapeutics, gave U.S. health care first-time share sales its best month since October.

U.S. Inflation gauge rises as Trump's tariff threats loom, potentially pushing prices higher in coming months.

Following the round number theme, $675 and $650 are the two levels that stand out as Buy the Dip targets. While these prices ...

The NYMEX front-month gold contract (GC00) late Thursday rose above $2,850 an ounce for the first time as Goldman Sachs reiterated its $3,000 price target, saying the yellow metal was a hedge against ...

Stock futures are higher Friday morning as investors respond to a steady stream of earnings reports and await the release of a closely followed inflation indicator.